Cargando…

Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other

BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell po...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherm, Martin G., Wyatt, Rebecca C., Serr, Isabelle, Anz, David, Richardson, Sarah J., Daniel, Carolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418549/
https://www.ncbi.nlm.nih.gov/pubmed/35944899
http://dx.doi.org/10.1016/j.molmet.2022.101565
_version_ 1784776971096424448
author Scherm, Martin G.
Wyatt, Rebecca C.
Serr, Isabelle
Anz, David
Richardson, Sarah J.
Daniel, Carolin
author_facet Scherm, Martin G.
Wyatt, Rebecca C.
Serr, Isabelle
Anz, David
Richardson, Sarah J.
Daniel, Carolin
author_sort Scherm, Martin G.
collection PubMed
description BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell populations and the pancreatic islets. SCOPE OF REVIEW: In this review article, we aim to discuss important recent insights into the multiple layers of interaction between immune cell populations and the pancreatic islets. Specifically, we discuss the environment where immune and beta cell interactions occur, the key cell types and molecules involved, and the outcomes of these interactions. MAJOR CONCLUSIONS: Most of the molecular mechanisms underlying aberrant immune cell activation and impaired immune tolerance remain insufficiently understood, which hinders the development of efficient prevention and treatment strategies. In order to overcome this knowledge gap, a better understanding of the complex interactions of immune cells and beta cells, including both the underlying protective and pathogenic mechanisms is urgently required.
format Online
Article
Text
id pubmed-9418549
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94185492022-08-28 Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other Scherm, Martin G. Wyatt, Rebecca C. Serr, Isabelle Anz, David Richardson, Sarah J. Daniel, Carolin Mol Metab Review BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell populations and the pancreatic islets. SCOPE OF REVIEW: In this review article, we aim to discuss important recent insights into the multiple layers of interaction between immune cell populations and the pancreatic islets. Specifically, we discuss the environment where immune and beta cell interactions occur, the key cell types and molecules involved, and the outcomes of these interactions. MAJOR CONCLUSIONS: Most of the molecular mechanisms underlying aberrant immune cell activation and impaired immune tolerance remain insufficiently understood, which hinders the development of efficient prevention and treatment strategies. In order to overcome this knowledge gap, a better understanding of the complex interactions of immune cells and beta cells, including both the underlying protective and pathogenic mechanisms is urgently required. Elsevier 2022-08-06 /pmc/articles/PMC9418549/ /pubmed/35944899 http://dx.doi.org/10.1016/j.molmet.2022.101565 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Scherm, Martin G.
Wyatt, Rebecca C.
Serr, Isabelle
Anz, David
Richardson, Sarah J.
Daniel, Carolin
Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title_full Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title_fullStr Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title_full_unstemmed Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title_short Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
title_sort beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418549/
https://www.ncbi.nlm.nih.gov/pubmed/35944899
http://dx.doi.org/10.1016/j.molmet.2022.101565
work_keys_str_mv AT schermmarting betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother
AT wyattrebeccac betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother
AT serrisabelle betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother
AT anzdavid betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother
AT richardsonsarahj betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother
AT danielcarolin betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother